Osteosarcoma
📧 Sign up to get email alerts when something new happens for Osteosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors [Phase 2]
Phase 2 trial results for cixutumumab in relapsed or refractory solid tumors across multiple sarcomas and pediatric cancers.
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma [Phase 2]
A Phase 2 trial tested inhaled sargramostim for patients with first pulmonary recurrence of osteosarcoma. The study has completed and result…
-
CLINICAL_TRIALS trial_result · 2015-02-27Clinical Trial Update: Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors [Phase 1]
This dose-escalation Phase 1 trial evaluated the safety and tolerability of combining Sorafenib with Irinotecan in pediatric patients with s…
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED) [Phase 2]
This update reports the completion of a Phase 2 trial of ridaforolimus (AP23573/MK-8669), an mTOR inhibitor, in patients with advanced sarco…
-
CLINICAL_TRIALS trial_result · 2014-11-25Clinical Trial Update: Huntsman Biopsy Study
The Huntsman Biopsy Study (NCT00615329) has been terminated according to the latest clinical trial status update.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-11-14Clinical Trial Update: Ixabepilone in Treating Young Patients With Refractory Solid Tumors [Phase 2]
Phase 2 trial update on ixabepilone in young patients with refractory solid tumors. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2014-10-02Clinical Trial Update: Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung [Phase 2]
Phase 2 study evaluating REOLYSIN (pelareorep) for bone and soft tissue sarcomas metastatic to the lung has been completed, assessing safety…
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma [Phase 2]
Phase 2 trial of high-dose methotrexate with leucovorin rescue, with or without glucarpidase, in osteosarcoma was terminated; results were p…
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy [NA]
This clinical trial update reports the termination of a study in osteosarcoma evaluating doxorubicin with cisplatin, high-dose methotrexate,…
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma [Phase 3]
A Phase 3 trial evaluating adding dexrazoxane to standard chemotherapy for newly diagnosed nonmetastatic osteosarcoma has completed. The stu…
-
CLINICAL_TRIALS trial_result · 2014-08-04Clinical Trial Update: A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma [Phase 2]
Phase 2 trial assessing bevacizumab in combination with chemotherapy for osteosarcoma and malignant fibrous histiocytoma of bone has complet…
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma [Phase 1]
Phase 1 study evaluating zoledronic acid added to combination chemotherapy for newly diagnosed metastatic osteosarcoma; results have been po…
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze [Phase 1]
Open-label pharmacokinetic study of leucovorin in patients receiving high-dose methotrexate, with or without Voraxaze, completed Phase 1.
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: Mifamurtide (L-MTP-PE) for High-Risk Osteosarcoma
The entry reports the completion of a clinical trial evaluating mifamurtide (L-MTP-PE) for high-risk osteosarcoma, summarizing outcomes for …
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia [Phase 1]
Phase 1 trial of eltrombopag for preventing chemotherapy-induced thrombocytopenia in soft tissue sarcoma and osteosarcoma has been terminate…
-
CLINICAL_TRIALS trial_result · 2014-03-28Clinical Trial Update: A Clinical Trial on Efficacy and Safety for Lobaplatin and Gemcitabine in Combination With Docetaxel in the Second-line Treatments on Advanced Osteosarcoma [Phase 2, Phase 3]
This clinical trial update describes a Phase 2/3 study evaluating the combination of lobaplatin and gemcitabine with docetaxel for second-li…
-
CLINICAL_TRIALS trial_result · 2014-03-17Clinical Trial Update: Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07) [Phase 2]
Phase 2 clinical trial evaluating sorafenib in patients with soft tissue sarcomas, including metastatic and recurrent subtypes; results were…
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial results for Therapeutic Angiotensin-(1-7) in patients with unresectable metastatic sarcoma have results posted.
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response [Phase 1]
This Phase 1 trial studying pre-operative chemotherapy with doxorubicin, ifosfamide, etoposide, and cisplatin for newly diagnosed surgically…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas [Phase 1]
A Phase 1 study of flavopiridol in children with relapsed or refractory solid tumors or lymphomas has completed, focusing on safety and dosi…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Trastuzumab in Treating Patients With Recurrent Osteosarcoma [Phase 2]
A Phase 2 clinical trial evaluating trastuzumab for recurrent osteosarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer [Phase 2]
A Phase 2 clinical trial evaluating combination chemotherapy and radiation therapy for Wilms tumor, Ewing's sarcoma, peripheral primitive ne…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Ecteinascidin 743 in Treating Patients With Previously Treated Metastatic Osteosarcoma [Phase 2]
Phase 2 trial evaluating ecteinascidin-743 (trabectedin) in patients with previously treated metastatic osteosarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment [Phase 2]
Phase 2 trial evaluating oxaliplatin in young patients with recurrent solid tumors that have not responded to prior treatment has completed.…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors [Phase 1]
Completed Phase 1 trial evaluating tanespimycin in pediatric patients with recurrent or refractory leukemia or solid tumors.